{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:05:54Z","timestamp":1782252354342,"version":"3.54.5"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Survivin plays important roles in maintaining cell proliferation and survival and promoting tumorigenesis. The present study was conducted to determine the stage of lung carcinogenesis at which survivin expression is induced and to investigate how survivin affects the chemopreventive action of deguelin. In in vitro studies, we observed higher levels of survivin expression in a subset of premalignant and malignant human bronchial epithelial (HBE) and non\u2013small-cell lung cancer (NSCLC) cell lines than in normal HBE cells, and in in vivo studies, a higher level of survivin expression in specimen of human lung dysplasia than in normal lung specimens. Treatment with deguelin inhibited de novo synthesis of survivin protein and induced apoptosis, resulting in suppression of transformation phenotypes, in the premalignant and malignant HBE and NSCLC cell lines. Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active. Deguelin induced activation of AMP-activated protein kinase (AMPK) and inactivation of Akt. Overexpression of constitutively active Akt abolished deguelin-induced modulation of AMPK activity and survivin expression. Conversely, inactivation of AMPK by compound C or AMPK\u03b11\/2 small interfering RNA restored Akt and mTOR activities and survivin expression in deguelin-treated HBE cells. These results suggest that survivin expression is induced as an early event in lung carcinogenesis, and deguelin acts as a chemopreventive agent by inducing a reciprocal regulation between AMPK and Akt, resulting in the inhibition of mTOR-mediated survivin. [Cancer Res 2007;67(23):11630\u20139]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-2401","type":"journal-article","created":{"date-parts":[[2007,12,18]],"date-time":"2007-12-18T18:52:12Z","timestamp":1198003932000},"page":"11630-11639","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Implication of AMP-Activated Protein Kinase and Akt-Regulated Survivin in Lung Cancer Chemopreventive Activities of Deguelin"],"prefix":"10.1158","volume":"67","author":[{"given":"Quanri","family":"Jin","sequence":"first","affiliation":[{"name":"1Thoracic\/Head and Neck Medical Oncology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Feng","sequence":"additional","affiliation":[{"name":"2Biostatistics and Applied Mathematics,"},{"name":"3Cancer Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Behrens","sequence":"additional","affiliation":[{"name":"1Thoracic\/Head and Neck Medical Oncology, Departments of"},{"name":"4Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Nebiyou","family":"Bekele","sequence":"additional","affiliation":[{"name":"2Biostatistics and Applied Mathematics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[{"name":"1Thoracic\/Head and Neck Medical Oncology, Departments of"},{"name":"4Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waun-Ki","family":"Hong","sequence":"additional","affiliation":[{"name":"1Thoracic\/Head and Neck Medical Oncology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"1Thoracic\/Head and Neck Medical Oncology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,12,18]]},"reference":[{"key":"2022061623231177700_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin\u20082007; 57: 43\u201366.","DOI":"10.3322\/canjclin.57.1.43"},{"key":"2022061623231177700_B2","doi-asserted-by":"crossref","unstructured":"Spurgers KB, Chari NS, Bohnenstiehl NL, et al. Molecular mediators of cell death in multistep carcinogenesis: a path to targeted therapy. Cell Death Differ\u20082006; 13: 1360\u201370.","DOI":"10.1038\/sj.cdd.4401986"},{"key":"2022061623231177700_B3","unstructured":"Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res\u20081998; 58: 5315\u201320."},{"key":"2022061623231177700_B4","doi-asserted-by":"crossref","unstructured":"Colnaghi R, Connell CM, Barrett RM, et al. Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem\u20082006; 281: 33450\u20136.","DOI":"10.1074\/jbc.C600164200"},{"key":"2022061623231177700_B5","unstructured":"Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol\u20081998; 152: 43\u20139."},{"key":"2022061623231177700_B6","doi-asserted-by":"crossref","unstructured":"Falleni M, Pellegrini C, Marchetti A, et al. Survivin gene expression in early-stage non-small cell lung cancer. J Pathol\u20082003; 200: 620\u20136.","DOI":"10.1002\/path.1388"},{"key":"2022061623231177700_B7","doi-asserted-by":"crossref","unstructured":"Vaira V, Lee CW, Goel HL, et al. Regulation of survivin expression by IGF-1\/mTOR signaling. Oncogene\u20082007; 26: 2678\u201384.","DOI":"10.1038\/sj.onc.1210094"},{"key":"2022061623231177700_B8","doi-asserted-by":"crossref","unstructured":"Stromberg T, Dimberg A, Hammarberg A, et al. Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. Blood\u20082004; 103: 3138\u201347.","DOI":"10.1182\/blood-2003-05-1543"},{"key":"2022061623231177700_B9","doi-asserted-by":"crossref","unstructured":"Ma L, Chen Z, Erdjument-Bromage H, et al. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell\u20082005; 121: 179\u201393.","DOI":"10.1016\/j.cell.2005.02.031"},{"key":"2022061623231177700_B10","doi-asserted-by":"crossref","unstructured":"Inoki K, Li Y, Zhu T, et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol\u20082002; 4: 648\u201357.","DOI":"10.1038\/ncb839"},{"key":"2022061623231177700_B11","doi-asserted-by":"crossref","unstructured":"Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell\u20082003; 115: 577\u201390.","DOI":"10.1016\/S0092-8674(03)00929-2"},{"key":"2022061623231177700_B12","doi-asserted-by":"crossref","unstructured":"Hardie DG. The AMP-activated protein kinase pathway\u2014new players upstream and downstream. J Cell Sci\u20082004; 117: 5479\u201387.","DOI":"10.1242\/jcs.01540"},{"key":"2022061623231177700_B13","doi-asserted-by":"crossref","unstructured":"Woods A, Johnstone SR, Dickerson K, et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol\u20082003; 13: 2004\u20138.","DOI":"10.1016\/j.cub.2003.10.031"},{"key":"2022061623231177700_B14","doi-asserted-by":"crossref","unstructured":"Bolster DR, Crozier SJ, Kimball SR, et al. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem\u20082002; 277: 23977\u201380.","DOI":"10.1074\/jbc.C200171200"},{"key":"2022061623231177700_B15","doi-asserted-by":"crossref","unstructured":"Rattan R, Giri S, Singh AK, et al. 5-Aminoimidazole-4-carboxamide-1-\u03b2-d-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem\u20082005; 280: 39582\u201393.","DOI":"10.1074\/jbc.M507443200"},{"key":"2022061623231177700_B16","doi-asserted-by":"crossref","unstructured":"Bueno OF, De Windt LJ, Tymitz KM, et al. The MEK1-1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J\u20082000; 19: 6341\u201350.","DOI":"10.1093\/emboj\/19.23.6341"},{"key":"2022061623231177700_B17","doi-asserted-by":"crossref","unstructured":"Hahn-Windgassen A, Nogueira V, Chen CC, et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem\u20082005; 280: 32081\u20139.","DOI":"10.1074\/jbc.M502876200"},{"key":"2022061623231177700_B18","doi-asserted-by":"crossref","unstructured":"King TD, Song L, Jope RS. AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. Biochem Pharmacol\u20082006; 71: 1637\u201347.","DOI":"10.1016\/j.bcp.2006.03.005"},{"key":"2022061623231177700_B19","doi-asserted-by":"crossref","unstructured":"Tzatsos A, Tsichlis PN. Energy depletion inhibits phosphatidylinositol 3-kinase\/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser794. J Biol Chem. In press 2007.","DOI":"10.1074\/jbc.M610101200"},{"key":"2022061623231177700_B20","doi-asserted-by":"crossref","unstructured":"Gerhauser C, Mar W, Lee SK, et al. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat Med\u20081995; 1: 260\u20136.","DOI":"10.1038\/nm0395-260"},{"key":"2022061623231177700_B21","doi-asserted-by":"crossref","unstructured":"Chun KH, Kosmeder JW II, Sun S, et al. Effects of deguelin on the phosphatidylinositol 3-kinase\/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst\u20082003; 95: 291\u2013302.","DOI":"10.1093\/jnci\/95.4.291"},{"key":"2022061623231177700_B22","doi-asserted-by":"crossref","unstructured":"Lee HY, Oh SH, Woo JK, et al. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. J Natl Cancer Inst\u20082005; 97: 1695\u20139.","DOI":"10.1093\/jnci\/dji377"},{"key":"2022061623231177700_B23","unstructured":"Udeani GO, Gerhauser C, Thomas CF, et al. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Res\u20081997; 57: 3424\u20138."},{"key":"2022061623231177700_B24","doi-asserted-by":"crossref","unstructured":"Gills JJ, Kosmeder J II, Moon RC, et al. Effect of deguelin on UVB-induced skin carcinogenesis. J Chemother\u20082005; 17: 297\u2013301.","DOI":"10.1179\/joc.2005.17.3.297"},{"key":"2022061623231177700_B25","doi-asserted-by":"crossref","unstructured":"Klein-Szanto AJ, Iizasa T, Momiki S, et al. A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc Natl Acad Sci U S A\u20081992; 89: 6693\u20137.","DOI":"10.1073\/pnas.89.15.6693"},{"key":"2022061623231177700_B26","doi-asserted-by":"crossref","unstructured":"Zhang H, Bajraszewski N, Wu E, et al. PDGFRs are critical for PI3K\/Akt activation and negatively regulated by mTOR. J Clin Invest\u20082007; 117: 730\u20138.","DOI":"10.1172\/JCI28984"},{"key":"2022061623231177700_B27","doi-asserted-by":"crossref","unstructured":"Lee HY, Oh SH, Suh YA, et al. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase\/Akt- and MAPK kinase 4\/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer. Clin Cancer Res\u20082005; 11: 6065\u201374.","DOI":"10.1158\/1078-0432.CCR-05-0009"},{"key":"2022061623231177700_B28","unstructured":"Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Tumours of the lung. In: Travis WD, Brambilla E, editors. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. p. 68\u201377."},{"key":"2022061623231177700_B29","doi-asserted-by":"crossref","unstructured":"Han JY, Oh SH, Morgillo F, et al. Hypoxia-inducible factor 1\u03b1 and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. J Natl Cancer Inst\u20082005; 97: 1272\u201386.","DOI":"10.1093\/jnci\/dji251"},{"key":"2022061623231177700_B30","doi-asserted-by":"crossref","unstructured":"Lee HY, Moon H, Chun KH, et al. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells. J Natl Cancer Inst\u20082004; 96: 1536\u201348.","DOI":"10.1093\/jnci\/djh286"},{"key":"2022061623231177700_B31","doi-asserted-by":"crossref","unstructured":"Hofmann HS, Simm A, Hammer A, et al. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol\u20082002; 128: 554\u201360.","DOI":"10.1007\/s00432-002-0364-z"},{"key":"2022061623231177700_B32","unstructured":"Tsao AS, McDonnell T, Lam S, et al. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prev\u20082003; 12: 660\u20134."},{"key":"2022061623231177700_B33","doi-asserted-by":"crossref","unstructured":"Lu B, Gonzalez A, Massion PP, et al. Nuclear survivin as a biomarker for non-small-cell lung cancer. Br J Cancer\u20082004; 91: 537\u201340.","DOI":"10.1038\/sj.bjc.6602027"},{"key":"2022061623231177700_B34","doi-asserted-by":"crossref","unstructured":"Knauer SK, Kramer OH, Knosel T, et al. Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J\u20082007; 21: 207\u201316.","DOI":"10.1096\/fj.06-5741com"},{"key":"2022061623231177700_B35","unstructured":"Lonardo F, Dragnev KH, Freemantle SJ, et al. Evidence for the epidermal growth factor receptor as a target for lung cancer prevention. Clin Cancer Res\u20082002; 8: 54\u201360."},{"key":"2022061623231177700_B36","doi-asserted-by":"crossref","unstructured":"Ghosh S, Tergaonkar V, Rothlin CV, et al. Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-\u03baB activation and cell survival. Cancer Cell\u20082006; 10: 215\u201326.","DOI":"10.1016\/j.ccr.2006.08.007"},{"key":"2022061623231177700_B37","doi-asserted-by":"crossref","unstructured":"Tamm I, Richter S, Oltersdorf D, et al. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin Cancer Res\u20082004; 10: 3737\u201344.","DOI":"10.1158\/1078-0432.CCR-03-0642"},{"key":"2022061623231177700_B38","doi-asserted-by":"crossref","unstructured":"Mesri M, Wall NR, Li J, et al. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest\u20082001; 108: 981\u201390.","DOI":"10.1172\/JCI200112983"},{"key":"2022061623231177700_B39","doi-asserted-by":"crossref","unstructured":"Dasgupta P, Kinkade R, Joshi B, et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A\u20082006; 103: 6332\u20137.","DOI":"10.1073\/pnas.0509313103"},{"key":"2022061623231177700_B40","unstructured":"Olie RA, Simoes-Wust AP, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res\u20082000; 60: 2805\u20139."},{"key":"2022061623231177700_B41","doi-asserted-by":"crossref","unstructured":"Xiang R, Mizutani N, Luo Y, et al. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res\u20082005; 65: 553\u201361.","DOI":"10.1158\/0008-5472.553.65.2"},{"key":"2022061623231177700_B42","doi-asserted-by":"crossref","unstructured":"Konno R, Yamakawa H, Utsunomiya H, et al. Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod\u20082000; 6: 529\u201334.","DOI":"10.1093\/molehr\/6.6.529"},{"key":"2022061623231177700_B43","doi-asserted-by":"crossref","unstructured":"Fortugno P, Beltrami E, Plescia J, et al. Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A\u20082003; 100: 13791\u20136.","DOI":"10.1073\/pnas.2434345100"},{"key":"2022061623231177700_B44","doi-asserted-by":"crossref","unstructured":"Oh SH, Woo JK, Yazici YD, et al. Structural basis for depletion of heat shock protein 90 client proteins by deguelin. J Natl Cancer Inst\u20082007; 99: 949\u201361.","DOI":"10.1093\/jnci\/djm007"},{"key":"2022061623231177700_B45","doi-asserted-by":"crossref","unstructured":"Peng XH, Karna P, O'Regan RM, et al. Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells. Mol Pharmacol\u20082007; 71: 101\u201311.","DOI":"10.1124\/mol.106.027367"},{"key":"2022061623231177700_B46","doi-asserted-by":"crossref","unstructured":"Hwang JT, Kim YM, Surh YJ, et al. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells. Cancer Res\u20082006; 66: 10057\u201363.","DOI":"10.1158\/0008-5472.CAN-06-1814"},{"key":"2022061623231177700_B47","doi-asserted-by":"crossref","unstructured":"He G, Sung YM, Digiovanni J, et al. Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity. Cancer Res\u20082006; 66: 1873\u20138.","DOI":"10.1158\/0008-5472.CAN-05-3111"},{"key":"2022061623231177700_B48","doi-asserted-by":"crossref","unstructured":"Zakikhani M, Dowling R, Fantus IG, et al. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res\u20082006; 66: 10269\u201373.","DOI":"10.1158\/0008-5472.CAN-06-1500"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/24\/11630\/2578632\/11630.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/24\/11630\/2578632\/11630.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:17:57Z","timestamp":1655435877000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/24\/11630\/534031\/Implication-of-AMP-Activated-Protein-Kinase-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,15]]},"references-count":48,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2007,12,18]]},"published-print":{"date-parts":[[2007,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-2401","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,15]]}}}